The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
MYC and Prostate Cancer
Open accessAbstract
Prostate cancer, the majority of which is adenocarcinoma, is the most common epithelial cancer affecting a majority of elderly men in Western nations. Its manifestation, however, varies from clinically asymptomatic insidious neoplasms that progress slowly and do not threaten life to one that is highly aggressive with a propensity for metastatic spread and lethality if not treated in time. A number of somatic genetic and epigenetic alterations occur in prostate cancer cells. Some of these changes, such as loss of the tumor suppressors PTEN and p53, are linked to disease progression. Others, such as ETS gene fusions, appear to be linked more with early phases of the disease, such as invasion. Alterations in chromosome 8q24 in the region of MYC have also been linked to disease aggressiveness for many years. However, a number of recent studies in human tissues have indicated that MYC appears to be activated at the earliest phases of prostate cancer (e.g., in tumor-initiating cells) in prostatic intraepithelial neoplasia, a key precursor lesion to invasive prostatic adenocarcinoma. The initiation and early progression of prostate cancer can be recapitulated in genetically engineered mouse models, permitting a richer understanding of the cause and effects of loss of tumor suppressors and activation of MYC. The combination of studies using human tissues and mouse models paints an emerging molecular picture of prostate cancer development and early progression. This picture reveals that MYC contributes to disease initiation and progression by stimulating an embryonic stem cell-like signature characterized by an enrichment of genes involved in ribosome biogenesis and by repressing differentiation. These insights pave the way to potential novel therapeutic concepts based on MYC biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Rhodes, D. R., Kalyana-Sundaram, S., Mahavisno, V., Varambally, R., Yu, J., Briggs, B. B., Barrette, T. R., Anstet, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,060
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Inflammation in prostate carcinogenesis
De Marzo, A. M., Platz, E. A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2090 · Cited by 1,621
Self-citationTherapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationPolycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,292
Self-citationGenome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,158
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Transcriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S., Minichiello, M. J., Fearnhead, P., Yu, K., Chatterjee, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2022 · Cited by 1,122
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Varambally, S., Cao, Q., Mani, R.-S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,052
MYC as a regulator of ribosome biogenesis and protein synthesis
van Riggelen, J., Yetil, A., & Felsher, D. W. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2819 · Cited by 956
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 855
Yu, J., Yu, J., Mani, R.-S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.018 · Cited by 850
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
Ellwood-Yen, K., Graeber, T. G., Wongvipat, J., Iruela-Arispe, M. L., Zhang, J., Matusik, R., Thomas, G. V., & Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00197-1 · Cited by 816
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
A common variant associated with prostate cancer in European and African populations
Amundadottir, L. T., Sulem, P., Gudmundsson, J., Helgason, A., Baker, A., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Cazier, J.-B., Sainz, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1808 · Cited by 787
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.158 · Cited by 758
Molecular genetics of prostate cancer
Abate-Shen, C., & Shen, M. M. (2000) · Genes & Development · doi:10.1101/gad.819500 · Cited by 735
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Wang, X., Julio, M. K.-D., Economides, K. D., Walker, D., Yu, H., Halili, M. V., Hu, Y.-P., Price, S. M., Abate-Shen, C., & Shen, M. M. (2009) · Nature · doi:10.1038/nature08361 · Cited by 734
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
Wong, D. J., Liu, H., Ridky, T. W., Cassarino, D., Segal, E., & Chang, H. Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.009 · Cited by 720
Roles for Nkx3.1 in prostate development and cancer
Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai, N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.966 · Cited by 665
Recurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1944 · Cited by 654
Self-citationWang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cumulative Association of Five Genetic Variants with Prostate Cancer
Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G., Adami, H.-O., Hsu, F.-C., Zhu, Y., Bälter, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075819 · Cited by 631
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A., Penney, K., Steen, R. G., Ardlie, K., John, E. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605832103 · Cited by 612
Metastatic prostate cancer in a transgenic mouse.
Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., & Greenberg, N. M. (1996) · PubMed · Cited by 599
Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer
Yegnasubramanian, S., Kowalski, J., Gonzalgo, M. L., Zahurak, M., Piantadosi, S., Walsh, P. C., Bova, G. S., De Marzo, A. M., Isaacs, W. B., & Nelson, W. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3972 · Cited by 527
Self-citationvan Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., & Berns, A. (1989) · Cell · doi:10.1016/0092-8674(89)90589-8 · Cited by 496
Skowroński, R., Peehl, D. M., & Feldman, D. I. (1993) · Endocrinology · doi:10.1210/en.132.5.1952 · Cited by 494
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
Ahonen, M. H., Tenkanen, L., Teppo, L., Hakama, M., & Tuohimaa, P. (2000) · Cancer Causes & Control · doi:10.1023/a:1008923802001 · Cited by 494
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
Definition of regions in human c-myc that are involved in transformation and nuclear localization.
Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., & Lee, W. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1697 · Cited by 447
Jenkins, R. B., Qian, J., Lieber, M. M., & Bostwick, D. G. (1997) · PubMed · Cited by 443
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Gurel, B., Iwata, T., M Koh, C., Jenkins, R. B., Lan, F., Van Dang, C., Hicks, J. L., Morgan, J., Cornish, T. C., Sutcliffe, S., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.111 · Cited by 441
Self-citationRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2006) · Journal of Urology · doi:10.1016/s0022-5347(06)00096-6 · Cited by 435
Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Stattin, P., Harvei, S., Hakulinen, T., Luostarinen, T., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11375 · Cited by 428
TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
Perner, S., Mosquera, J.-M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J., Collins, C., Bismar, T. A., Chinnaiyan, A. M., De Marzo, A. M., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213424.38503.aa · Cited by 426
Self-citationXin, L., Lawson, D. A., & Witte, O. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502320102 · Cited by 423
The Life Cycle of C-Myc: From Synthesis to Degradation
Sears, R. C. (2004) · Cell Cycle · doi:10.4161/cc.3.9.1145 · Cited by 417
Isolation and functional characterization of murine prostate stem cells
Lawson, D. A., Xin, L., Lukacs, R. U., Cheng, D., & Witte, O. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609684104 · Cited by 399
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sander, S., Bullinger, L., Klapproth, K., Fiedler, K., Kestler, H. A., Barth, T. F. E., Möller, P., Stilgenbauer, S., Pollack, J. R., & Wirth, T. (2008) · Blood · doi:10.1182/blood-2008-03-147645 · Cited by 395
Telomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., & Coffey, D. S. (1996) · PubMed · Cited by 391
Myc influences global chromatin structure
Knoepfler, P. S., Zhang, X., Cheng, P. F., Gafken, P. R., McMahon, S. B., & Eisenman, R. N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601152 · Cited by 383
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Bowen, C., Bubendorf, L., Voeller, H. J., Slack, R., Willi, N., Sauter, G., Gasser, T. C., Koivisto, P., Lack, E. E., Kononen, J., et al. (2000) · PubMed · Cited by 377
He, W. W., Sciavolino, P. J., Wing, J., Augustus, M., Hudson, P., Meissner, P. S., Curtis, R. T., Shell, B. K., Bostwick, D. G., Tindall, D. J., et al. (1997) · Genomics · doi:10.1006/geno.1997.4715 · Cited by 361
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
Goldstein, A. S., Lawson, D. A., Cheng, D., Sun, W., Garraway, I. P., & Witte, O. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811411106 · Cited by 340
Xu, D., Popov, N., Hou, M., Wang, Q., Björkholm, M., Gruber, A., Menkel, A. R., & Henriksson, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043198 · Cited by 325
Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Meeker, A. K., Hicks, J. L., Platz, E. A., March, G. E., Bennett, C., Delannoy, M. J., & Marzo, A. M. D. (2002) · PubMed · Cited by 313
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Nupponen, N. N., Kakkola, L., Koivisto, P., & Visakorpi, T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65554-x · Cited by 307
McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z., & Newman, R. A. (2000) · PubMed · Cited by 304
Multiple loci on 8q24 associated with prostate cancer susceptibility
The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Al Olama, A. A., Collaborators, T. U. P. T. F. C. A. T. S. (. S., Kote-Jarai, Z., Giles, G. G., Guy, M., Morrison, J., Severi, G., Leongamornlert, D. A., Tymrakiewicz, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.452 · Cited by 295
Hepsin promotes prostate cancer progression and metastasis
Klezovitch, O., Chevillet, J., Mirosevich, J., Roberts, R. L., Matusik, R. J., & Vasioukhin, V. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.008 · Cited by 282
Serum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study
Ahn, J., Peters, U., Albanes, D., Purdue, M. P., Abnet, C. C., Chatterjee, N., Horst, R. L., Hollis, B. W., Huang, W.-Y., Shikany, J. M., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn152 · Cited by 282
Nuclear Localization and DNA Binding Properties of a Protein Expressed by Human c- myc Oncogene
Persson, H., & Leder, P. (1984) · Science · doi:10.1126/science.6463648 · Cited by 281
Zippo, A., De Robertis, A., Serafini, R., & Oliviero, S. (2007) · Nature Cell Biology · doi:10.1038/ncb1618 · Cited by 273
Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
Lapointe, J., Li, C., Giacomini, C. P., Salari, K., Huang, S., Wang, P., Ferrari, M., Hernandez-Boussard, T., Brooks, J. D., & Pollack, J. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0673 · Cited by 269
MicroRNA-26a Targets the Histone Methyltransferase Enhancer of Zeste homolog 2 during Myogenesis
Wong, C. F., & Tellam, R. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709614200 · Cited by 261
Burger, P. E., Xiong, X., Coetzee, S., Salm, S. N., Moscatelli, D., Goto, K., & Wilson, E. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502761102 · Cited by 261
Sun, C., Dobi, A., Mohamed, A., Li, H., Thangapazham, R. L., Furusato, B., Shaheduzzaman, S., Tan, S.-H., Vaidyanathan, G., Whitman, E., et al. (2008) · Oncogene · doi:10.1038/onc.2008.183 · Cited by 253
Recognition and elongation of telomeres by telomerase
Blackburn, E. H., Greider, C. W., Henderson, E., Lee, M. S., Shampay, J., & Shippen-Lentz, D. (1989) · Genome · doi:10.1139/g89-104 · Cited by 244
Prostate-specific and Androgen-dependent Expression of a Novel Homeobox Gene
Bieberich, C. J., Fujita, K., He, W.-W., & Jay, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31779 · Cited by 239
Self-citationSTEM CELL FEATURES OF BENIGN AND MALIGNANT PROSTATE EPITHELIAL CELLS
DE MARZO, A. M., NELSON, W. G., MEEKER, A. K., & COFFEY, D. S. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62196-7 · Cited by 239
Self-citationLong-range enhancers on 8q24 regulate c-Myc
Sotelo, J., Esposito, D., Duhagon, M. A., Banfield, K., Mehalko, J., Liao, H., Stephens, R. M., Harris, T. J. R., Munroe, D. J., & Wu, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906067107 · Cited by 238
Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus
Jia, L., Landan, G., Pomerantz, M., Jaschek, R., Herman, P., Reich, D., Yan, C., Khalid, O., Kantoff, P., Oh, W., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000597 · Cited by 237
Sato, K., Qian, J., Slezak, J. M., Lieber, M. M., Bostwick, D. G., Bergstralh, E. J., & Jenkins, R. B. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1574 · Cited by 236
Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Risk of Advanced Prostate Cancer
John, E. M., Schwartz, G. G., Koo, J., Van Den Berg, D., & Ingles, S. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3134 · Cited by 235
Chiaverotti, T., Couto, S. S., Donjacour, A., Mao, J.-H., Nagase, H., Cardiff, R. D., Cunha, G. R., & Balmain, A. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070602 · Cited by 228
Masumori, N., Thomas, T. Z., Chaurand, P., Case, T. C., Paul, M., Kasper, S. F., Caprioli, R. M., Tsukamoto, T., Shappell, S. B., & Matusik, R. J. (2001) · PubMed · Cited by 228
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Wang, L., Liu, R., Li, W., Chen, C., Katoh, H., Chen, G.-Y., McNally, B., Lin, L., Zhou, P., Zuo, T., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.016 · Cited by 218
Molecular biology of prostatic intraepithelial neoplasia
Bostwick, D. G., Pacelli, A., & Lopez-Beltran, A. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199608)29:2<117::aid-pros7>3.0.co;2-c · Cited by 212
Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy
van Leenders, G. J. L. H., Gage, W. R., Hicks, J. L., van Balken, B., Aalders, T. W., Schalken, J. A., & De Marzo, A. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64286-1 · Cited by 212
Self-citationZong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203
Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers
Buttyan, R., Sawczuk, I. S., Benson, M. C., Siegal, J. D., & Olsson, C. A. (1987) · The Prostate · doi:10.1002/pros.2990110405 · Cited by 191
Kim, S., Li, Q., Dang, C. V., & Lee, L. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200372597 · Cited by 188
Self-citationStem cells in prostate cancer initiation and progression
Lawson, D. A., & Witte, O. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32810 · Cited by 179
Mulholland, D. J., Xin, L., Morim, A., Lawson, D., Witte, O., & Wu, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4673 · Cited by 179
Telomerase primer specificity and chromosome healing
Harrington, L. A., & Harrington, L. A. (1991) · Nature · doi:10.1038/353451a0 · Cited by 172
Schaeffer, E. M., Marchionni, L., Huang, Z., Simons, B., Blackman, A., Yu, W., Parmigiani, G., & Berman, D. M. (2008) · Oncogene · doi:10.1038/onc.2008.327 · Cited by 172
van Leenders, G., Dijkman, H., Hulsbergen-van de Kaa, C., Ruiter, D., & Schalken, J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780133 · Cited by 169
Van Quaquebeke, E., Simon, G., André, A., Dewelle, J., Yazidi, M. E., Bruyneel, F., Tuti, J., Nacoulma, O., Guissou, P., Decaestecker, C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049405a · Cited by 161
DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies
Sun, J., Liu, W., Adams, T. S., Sun, J., Li, X., Turner, A. R., Chang, B., Kim, J. W., Zheng, S. L., Isaacs, W. B., et al. (2007) · The Prostate · doi:10.1002/pros.20543 · Cited by 155
A Novel Role of Myosin VI in Human Prostate Cancer
Dunn, T. A., Chen, S., Faith, D., Hicks, J. L., Platz, E. A., Chen, Y., Ewing, C. M., Sauvageot, J., Isaacs, W. B., Marzo, A. M. D., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060316 · Cited by 154
Nupponen, N. N., Porkka, K., Kakkola, L., Tanner, M., Persson, K., Borg, Å., Isola, J. J., & Visakorpi, T. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65433-8 · Cited by 151
Minireview: Epigenetic Alterations in Human Prostate Cancers
Nelson, W. G., Marzo, A. M. D., & Yegnasubramanian, S. (2009) · Endocrinology · doi:10.1210/en.2009-0573 · Cited by 149
Self-citationPim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
Wang, J., Kim, J., Roh, M., Franco, O. E., Hayward, S. W., Wills, M. L., & Abdulkadir, S. A. (2010) · Oncogene · doi:10.1038/onc.2010.10 · Cited by 149
Zhang, W., Kapusta, L. R., Slingerland, J. M., & Klotz, L. H. (1998) · PubMed · Cited by 147
Saramäki, O. R., Tammela, T. L. J., MARTIKAINEN, P. M., Vessella, R. L., & Visakorpi, T. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20327 · Cited by 146
Iversen, P. L., Arora, V., Acker, A., Mason, D. H., & Devi, G. R. (2003) · PubMed · Cited by 145
Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer
Furusato, B., Gao, C., Ravindranath, L., Chen, Y., Cullen, J. C., McLeod, D. G., Dobi, A. L., Srivastava, S. K., Petrovics, G., & Sesterhenn, I. A. (2007) · Modern Pathology · doi:10.1038/modpathol.3800981 · Cited by 144
Kunderfranco, P., Mello-Grand, M., Cangemi, R., Pellini, S., Mensah, A., Albertini, V., Malek, A., Chiorino, G., Catapano, C. V., & Carbone, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010547 · Cited by 143
Fiorentino, M., Zadra, G., Palescandolo, E., Fedele, G., Bailey, D., Fiore, C., Nguyen, P. L., Migita, T., Zamponi, R., Vizio, D. D., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.97 · Cited by 139
Iwata, T., Schultz, D., Hicks, J. L., Hubbard, G. K., Mutton, L. N., Lotan, T. L., Bethel, C. R., Lotz, M. T., Yegnasubramanian, S., Nelson, W. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009427 · Cited by 137
Self-citationPim‐1 expression in prostatic intraepithelial neoplasia and human prostate cancer
Valdman, A., Fang, X., Pang, S., Ekman, P., & Egevad, L. (2004) · The Prostate · doi:10.1002/pros.20064 · Cited by 131
Beta-catenin signaling in prostate cancer: an early perspective.
Chesire, D. R., & Isaacs, W. B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100537 · Cited by 129
Molecular genetics of prostate cancer
Elo, J. P., & Visakorpi, T. (2001) · Annals of Medicine · doi:10.3109/07853890109002068 · Cited by 127
Yu, X., Wang, Y., Jiang, M., Bierie, B., Roy‐Burman, P., Shen, M. M., Taketo, M. M., Wills, M. L., & Matusik, R. J. (2008) · The Prostate · doi:10.1002/pros.20877 · Cited by 121
Dhanasekaran, S. M., Dash, A., Yu, J., Maine, I. P., Laxman, B., Tomlins, S. A., Creighton, C. J., Menon, A., Rubin, M. A., & Chinnaiyan, A. M. (2004) · The FASEB Journal · doi:10.1096/fj.04-2415fje · Cited by 121
Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer
Saramäki, O. R., Willi, N., Ola Bratt, A., Gasser, T. C., Koivisto, P., Nupponen, N. N., Bubendorf, L., & Visakorpi, T. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63060-x · Cited by 118
Coamplification of prostate stem cell antigen (PSCA) andMYC in locally advanced prostate cancer
Reiter, R. E., Sato, I., THOMAS, G. V., Qian, J., Gu, Z., Watabe, T., Loda, M. F., & Jenkins, R. B. (2000) · Genes Chromosomes and Cancer · Cited by 118
Huang, Y.-T., Chueh, S., Teng, C., & Guh, J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.013 · Cited by 116
Qian, J., Jenkins, R. B., & Bostwick, D. G. (1997) · PubMed · Cited by 113
Telomerase Activity in Primary Prostate Cancer
Lin, Y., Uemura, H., Fujinami, K., Hosaka, M., Harada, M., & Kubota, Y. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65160-7 · Cited by 113
Wnt Signaling and Prostate Cancer
Robinson, D., Diegel, C. R., & Williams, B. O. (2008) · Current Drug Targets · doi:10.2174/138945008784911831 · Cited by 112
Devi, G. R., Beer, T. M., Corless, C. L., Arora, V., Weller, D. L., & Iversen, P. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2091 · Cited by 111
Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression
Pomerantz, M. M., Beckwith, C. A., Regan, M. M., Wyman, S. K., Petrovics, G., Chen, Y., Hawksworth, D. J., Schumacher, F. R., Mucci, L. A., Penney, K. L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0387 · Cited by 111
Involvement of Cdk5/p25 in Digoxin-triggered Prostate Cancer Cell Apoptosis
Lin, H., Juang, J., & Wang, P. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403664200 · Cited by 108
Inactivation of Apc in the Mouse Prostate Causes Prostate Carcinoma
Bruxvoort, K. J., Charbonneau, H. M., Giambernardi, T. A., Goolsby, J. C., Qian, C.-N., Diegel, C. R., Robinson, D. R., Roy‐Burman, P., Shaw, A. K., Buckner-Berghuis, B. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3028 · Cited by 108
Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure
John, E. M., Koo, J., & Schwartz, G. G. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1053 · Cited by 108
Yeh, J., Huang, W. J., Kan, S., & Wang, P. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65724-2 · Cited by 106
htert expression correlates with MYC over-expression in human prostate cancer
Latil, A., Vidaud, D., Valéri, A., Fournier, G., Vidaud, M., Lidereau, R., Cussenot, O., & Biàche, I. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<172::aid-ijc12>3.0.co;2-8 · Cited by 105
Immortalization of primary human prostate epithelial cells by c-Myc
Gil, J., Kerai, P., Lleonart, M., Bernard, D., Cigudosa, J. C., Peters, G., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-4030 · Cited by 105
Berg, C. V. D., Guan, X., Hoff, D. V., et al. (1995) · PubMed · Cited by 103
Möröy, T., Verbeek, S. J., Ma, A. I., Achacoso, P., Berns, A. J. M., & Alt, F. W. (1991) · PubMed · Cited by 95
Molecular Mechanisms of Prostate Cancer
Porkka, K. P., & Visakorpi, T. (2004) · European Urology · doi:10.1016/j.eururo.2004.01.012 · Cited by 93
van Duin, M., van Marion, R., Vissers, K. J., Watson, J. E. V., van Weerden, W. M., Schröder, F. H., Hop, W. C. J., van der Kwast, T., Collins, C. C., & van Dekken, H. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20259 · Cited by 92
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
Kim, J., Eltoum, I., Roh, M., Wang, J., & Abdulkadir, S. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000542 · Cited by 88
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
Kim, J., Roh, M., & Abdulkadir, S. A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-248 · Cited by 87
Yang, G., Timme, T. L., Frolov, A., Wheeler, T. M., & Thompson, T. C. (2005) · Cancer · doi:10.1002/cncr.20905 · Cited by 86
Rohan, J. P., & Weigel, N. L. (2009) · Endocrinology · doi:10.1210/en.2008-1395 · Cited by 86
Molecular biology of prostate-cancer pathogenesis
Shand, R. L., & Gelmann, E. P. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000193384.39351.64 · Cited by 85
TELOMERASE ACTIVITY, TELOMERE LENGTH, AND DNA PLOIDY IN PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN)
Koeneman, K. S., Pan, C.-X., JIN, J.-K., Pyle, J. M., Flanigan, R. C., Shankey, T. V., & Dı́az, M. O. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62608-9 · Cited by 84
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
Porkka, K. P., Tammela, T. L. J., Vessella, R. L., & Visakorpi, T. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10289 · Cited by 83
Conserved Gene Expression Programs Integrate Mammalian Prostate Development and Tumorigenesis
Pritchard, C. C., Mecham, B., Dumpit, R. F., Coleman, I. M., Bhattacharjee, M., Chen, Q., Sikes, R. A., & Nelson, P. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6817 · Cited by 78
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype
Williams, K., Fernandez, S., Stien, X., Ishii, K., Love, H. D., Lau, Y. C., Roberts, R. L., & Hayward, S. W. (2004) · The Prostate · doi:10.1002/pros.20200 · Cited by 75
Alterations in β‐catenin expression and localization in prostate cancer
Whitaker, H. C., Girling, J., Warren, A. Y., Leung, H. Y., Mills, I. G., & Neal, D. E. (2008) · The Prostate · doi:10.1002/pros.20780 · Cited by 71
Review of allelic loss and gain in prostate cancer
Bova, G. S., & Isaacs, W. B. (1996) · World Journal of Urology · doi:10.1007/bf00184607 · Cited by 68
Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets
Gürel, B., Iwata, T., Koh, C. M., Yegnasubramanian, S., Nelson, W. G., & Marzo, A. M. D. (2008) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31818a5c19 · Cited by 66
Self-citationBalaji, K. C., Koul, H., Mitra, S., Maramag, C., Reddy, P., Menon, M., Kaur Malhotra, R., & Laxmanan, S. (1997) · Urology · doi:10.1016/s0090-4295(97)00390-7 · Cited by 57
Lamb, L. E., Knudsen, B. S., & Miranti, C. K. (2010) · Journal of Cell Science · doi:10.1242/jcs.054502 · Cited by 48
Mapping and Gene Expression Profile of the Minimally Overrepresented 8q24 Region in Prostate Cancer
Tsuchiya, N., Kondo, Y., Takahashi, A., Pawar, H. S., Qian, J., Sato, K., Lieber, M. M., & Jenkins, R. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61126-1 · Cited by 41
Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model
Nandana, S., Ellwood‐Yen, K., Sawyers, C. L., Wills, M. L., Weidow, B. L., Case, T. C., Vasioukhin, V. I., & Matusik, R. J. (2009) · The Prostate · doi:10.1002/pros.21093 · Cited by 39
Adenoviral E1A Function through Myc
Chakraborty, A. A., & Tansey, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3026 · Cited by 35
c‐Myc localization within the nucleus: Evidence for association with the PML nuclear body
Smith, K. P., Byron, M., O’Connell, B. C., Tam, R., Schorl, C., Guney, I., Hall, L. L., Agrawal, P., Sedivy, J. M., & Lawrence, J. B. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20273 · Cited by 28
Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells
van der Poel, H. G., Zevenhoven, J., & Bergman, A. M. (2010) · Urologia Internationalis · doi:10.1159/000277601 · Cited by 28
Telomere Length and Telomerase Activity in Bladder and Prostate Cancer Cell Lines
Kageyama, Y., Kamata, S., Yonese, J., & Oshima, H. (1997) · International Journal of Urology · doi:10.1111/j.1442-2042.1997.tb00216.x · Cited by 16
Dysplasia of human prostate CD133hi sub‐population in NOD‐SCIDS is blocked by c‐myc anti‐sense
Goodyear, S. M., Amatangelo, M. D., & Stearns, M. E. (2009) · The Prostate · doi:10.1002/pros.20918 · Cited by 15
Cited by
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Shorning, B. Y., Dass, M. S., Smalley, M. J., & Pearson, H. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124507 · Cited by 616
Banerjee, M., Cui, X., Li, Z., Yu, H., Cai, L., Jia, X., He, D., Wang, C., Gao, T., & Xie, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-29995-2 · Cited by 506
Hörnberg, E., Ylitalo, E. B., Crnalic, S., Antti, H., Stattin, P., Widmark, A., Bergh, A., & Wikström, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019059 · Cited by 498
The inflammatory microenvironment and microbiome in prostate cancer development
Sfanos, K. S., Yegnasubramanian, S., Nelson, W. G., & De Marzo, A. M. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2017.167 · Cited by 469
Self-citationCancer overdiagnosis: a biological challenge and clinical dilemma
Srivastava, S., Koay, E. J., Borowsky, A. D., De Marzo, A. M., Ghosh, S., Wagner, P. D., & Kramer, B. S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0142-8 · Cited by 337
Self-citation
Metadata
- Authors
- Koh, C. M., Bieberich, C. J., Dang, C. V., Nelson, W. G., Yegnasubramanian, S., & De Marzo, A. M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2010-06-01
- Volume
- 1
- Issue
- 6
- Pages
- 617-628
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2147200519
- Cited by
- 296
- References
- 149
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.